1-3 of 3
Sarah T Wilkinson, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lack of Major Histocompatibility Class II (MHCII) Protein and Decreased Immunosurveillance in Plasmablastic Lymphoma (PBL)

Monika Schmelz, PhD, Santiago Montes-Moreno, MD, Miguel Piris, MD, Sarah T Wilkinson, PhD, Lisa M. Rimsza, MD
Journal: Blood
Blood (2011) 118 (21): 5186.
https://doi.org/10.1182/blood.V118.21.5186.5186
Published: 2011
Journal Articles

A Comparison of Gene Expression Pattern in Major Histocompatibility Class II-Low Diffuse Large B-Cell Lymphoma with Plasmablastic Lymphoma.

Sarah T. Wilkinson, PhD, Roshanak Bob, MD, Harald Stein, MD, Mark Schwartz, PhD, Rita M. Braziel, MD, Randy D. Gascoyne, MD, Lisa M. Rimsza, MD
Journal: Blood
Blood (2009) 114 (22): 1941.
https://doi.org/10.1182/blood.V114.22.1941.1941
Published: 2009
Journal Articles

Loss of CIITA and MHC Class II Expression in Diffuse Large B-Cell Lymphoma Is Not Explained by Methylation of CIITA Promoters III and IV.

Sarah T Wilkinson, PhD, Diane R Fernandez, MD, Shawn P Murphy, PhD, Wing C. Chan, MD, Randy D. Gascoyne, MD, Elias Campo, MD, Elaine S. Jaffe, MD, Louis M. Staudt, MD, PhD, Jan Delabie, MD, PhD, Andreas Rosenwald, MD, Lisa M Rimsza, MD
Journal: Blood
Blood (2008) 112 (11): 1786.
https://doi.org/10.1182/blood.V112.11.1786.1786
Published: 2008